SCHEMBL31665020

SCHEMBL31665020

OCc1ccc(-c2ncc(C(F)(F)F)cc2F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.49
▸ TRPA1 O75762 1/20 0.40
▸ RXRA P19793 1/20 0.40
▸ RXRB P28702 1/20 0.40
▸ RXRG P48443 1/20 0.40
▸ TRPM8 Q7Z2W7 1/20 0.39
▸ PTGS2 P35354 2/20 0.38
▸ MAP2K4 P45985 1/20 0.38
▸ FYN P06241 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ AGBL2 Q5U5Z8 1/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ HTT P42858 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ EP300 Q09472 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29502570 0.88 AGBL2 (0.43) KIF11RXRARXRBRXRGTRPM8
SCHEMBL30767641 0.85 SMN1; SMN2 (0.40) TRPA1ALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL12970141 0.80 MAP2K4 (0.47) KIF11MAP2K4FYNPOLBEP300
SCHEMBL10762792 0.77 JAK3 (0.49) TRPA1ALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL2269528 0.73 KIF11 (0.51) KIF11FYN
SCHEMBL18975045 0.72 AGBL2 (0.47) ALDH1A1AGBL2RAB9AHTTGAA
SCHEMBL1781036 0.70 KIF11 (0.58) KIF11RXRARXRBRXRGPSEN1
SCHEMBL13267997 0.70 RXRA (0.64) KIF11RXRARXRBRXRGPSEN1
SCHEMBL31521744 0.69 MKNK1 (0.47) KIF11MAP2K4FYNALDH1A1KDM4E
SCHEMBL27174522 0.69 MKNK1 (0.47) KIF11MAP2K4FYNALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568960-B1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2026-04-29 — — EP disclosed
US-20250236614-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2025-07-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236614-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES GRIN2C, CNR1, CNR2 KIF11 2058/4885TRPA1 469/4885RXRA 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback